Ge Healthcare Technologies Inc (GEHC) Inventory Turnover Ratio, from first quarter 2026 to first quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
Ge Healthcare Technologies Inc   (NASDAQ: GEHC)
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

Ge Healthcare Technologies Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Ge Healthcare Technologies Inc inventory turnover ratio, the Ge Healthcare Technologies Inc 's ability to sell and replace its inventory in the first quarter 2026, sequentially increased to 4.04 in the first quarter 2026, GEHC's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Ge Healthcare Technologies Inc in Mar 31 2026 quarter, has decreased to 90 days, compare to 92 days, in the Dec 31 2025 quarter.

Within Healthcare sector 96 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 104 in the fourth quarter 2025, to 378.

GEHC Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Ge Healthcare Technologies Inc Market Share?

What is Inventory Turnover Ratio?




GEHC Inventory Turnover Ratio (Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
(Mar 31 2025)
I. Quarter
Y / Y Inventory Growth 9.04 % 15.21 % 8.47 % 12.85 % 8.5 %
Y / Y Cost of Sales Growth 16.3 % 14.51 % 11.66 % 5.62 % -0.2 %
Inventory Turnover Ratio (TTM) 4.04 3.98 3.97 3.94 4.01
GEHC's Total Ranking # 378 # 104 # 180 # 836 # 579
Average inventory processing period 90 92 92 93 91
Seq. Inventory Growth 5.33 % -3.04 % 0.92 % 5.79 % 11.29 %
Seq. Cost of Sales Growth -10.44 % 12.29 % 5.09 % 10.04 % -11.81 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Laboratories Industry # 10
Healthcare Sector # 97
Overall Market # 378

Inventory Turnover Ratio Statistics
High Average Low
4.13 4.02 3.93
(Jun 30 2024)   (Dec 31 2023)




Financial Statements
Ge Healthcare Technologies Inc 's Inventories $ 2,353 Millions Visit GEHC's Balance sheet
Ge Healthcare Technologies Inc 's Cost of Revenues TTM $ 9,262 Millions Visit GEHC's Income Statement
What are GEHC's Sales? Visit GEHC's Sales by Segment

Other Inventory Turnover Ratios
Ge Healthcare Technologies Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Laboratories Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
GEHC's Inventory Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for GEHC's Competitors
Inventory Turnover Ratio for GEHC's Suppliers
Inventory Turnover Ratio for GEHC's Customers

You may also want to know
GEHC's Sales Growth Rates GEHC's Pe Price to earnings ratio GEHC's Receivables Turnover Ratio GEHC's Stock Quote
GEHC's Net Income Growth Rates GEHC's Ps Price to Sales ratio GEHC's Sales per Employee GEHC's Asset Turnover Ratio
GEHC's Net Margin GEHC's Pb Price to Book ratio GEHC's Financial Strength Ratios GEHC's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2026 Inventories at quarter ending Mar 31 2026
Earth Science Tech Inc   10.81 $ 8.224  Millions$ 1  Millions
Option Care Health Inc   10.74 $ 4,579.720  Millions$ 427  Millions
Zevra Therapeutics Inc   10.44 $ 17.034  Millions$ 2  Millions
Alnylam Pharmaceuticals Inc   10.38 $ 814.503  Millions$ 78  Millions
Nutriband Inc   10.06 $ 1.291  Millions$ 0  Millions
Lantheus Holdings Inc   9.75 $ 610.000  Millions$ 63  Millions
Sotera Health Company  9.58 $ 531.000  Millions$ 55  Millions
Warby Parker Inc   9.23 $ 415.000  Millions$ 45  Millions
Tarsus Pharmaceuticals Inc   9.09 $ 37.864  Millions$ 4  Millions
National Vision Holdings Inc   8.90 $ 833.415  Millions$ 94  Millions
Myriad Genetics Inc   8.35 $ 248.000  Millions$ 30  Millions
Pulse Biosciences Inc   8.08 $ 0.909  Millions$ 0  Millions
Castle Biosciences Inc   7.97 $ 75.178  Millions$ 9  Millions
Moderna Inc   7.96 $ 1,733.000  Millions$ 218  Millions
Carlsmed Inc   7.95 $ 12.557  Millions$ 2  Millions
Inogen Inc   7.80 $ 195.741  Millions$ 25  Millions
Cardiff Lexington Corporation  7.70 $ 4.159  Millions$ 1  Millions
Novavax inc   7.67 $ 89.620  Millions$ 12  Millions
Prophase Labs Inc   7.64 $ 2.361  Millions$ 0  Millions
Bellevue Life Sciences Acquisition Corp  7.62 $ 1.986  Millions$ 0  Millions
Lifemd Inc   7.60 $ 24.000  Millions$ 3  Millions
Charles River Laboratories International inc   7.56 $ 2,346.239  Millions$ 310  Millions
Adaptive Biotechnologies Corporation  7.43 $ 73.088  Millions$ 10  Millions
Puma Biotechnology Inc   7.19 $ 58.025  Millions$ 8  Millions
Fonar Corporation  7.06 $ 19.685  Millions$ 3  Millions
Carlisle Companies Incorporated  6.71 $ 3,206.100  Millions$ 478  Millions
Hims and Hers Health Inc   6.58 $ 670.000  Millions$ 102  Millions
Vanda Pharmaceuticals Inc   6.54 $ 12.682  Millions$ 2  Millions
Twist Bioscience Corporation  6.50 $ 196.251  Millions$ 30  Millions
Phathom Pharmaceuticals Inc   6.48 $ 30.871  Millions$ 5  Millions

Date modified: 2026-09-08T15:11:40+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.